Darren G Woodside

Aviara Pharmaceuticals, Inc.

NIH Rank #8446
  • Early Career

NIH Funding · FY2024

Total Funding
$1.5M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#8,446
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.5M across 2 grants · National rank #8446.

Top grants by award amount

Darren G Woodside's NIH grant portfolio, ranked by award amount.

  • 5R42DK127869-03R42
    Selective targeting of high affinity alpha4 integrins as a safe treatment strategy for IBD
    $959.7K
    award amount
  • 5R61HL168737-02R61
    Targeting Integrin Signaling in Atherosclerosis
    $556.5K
    award amount

Affiliations

Institutions that have administered grants for Darren G Woodside.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Aviara Pharmaceuticals, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #8446
  5. 2024
    Multi-Institutional Research
    Awards at 2 institutions

Related investigators

Other NIH-funded PIs frequently associated with Darren G Woodside.